Literature DB >> 21458623

Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance.

Kiran B Tam Tam1, Eric George, Kathy Cockrell, Marietta Arany, Joshua Speed, James N Martin, Babbette Lamarca, Joey P Granger.   

Abstract

OBJECTIVE: We sought to determine the effect of an endothelin type A receptor antagonist (ETA) on uterine artery resistive index (UARI) and mean arterial pressure (MAP) in a placental ischemia rat model of preeclampsia produced by reduction in uterine perfusion pressure (RUPP). STUDY
DESIGN: UARI was assessed by Doppler velocimetry in RUPP and normal pregnant controls (NP) on gestational days (GD) 12, 15, and 18. UARI was also determined on GD 18 in NP and RUPP pregnant dams after pretreatment with ETA. MAP was recorded on GD 19.
RESULTS: The RUPP group had a higher MAP and UARI on GD 15 and 18 than the NP group. Pretreatment with ETA attenuated both the MAP and GD-18 UARI in the RUPP group without affecting these parameters in the NP group.
CONCLUSION: The improvement in UARI could be one potential mechanism for the reduction in MAP in response to ETA in pregnant dams with ischemic placentas.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458623      PMCID: PMC3072697          DOI: 10.1016/j.ajog.2011.01.049

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

1.  Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.

Authors:  B T Alexander; A N Rinewalt; K L Cockrell; M B Massey; W A Bennett; J P Granger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

2.  Endothelin and neuropeptide Y are vasoconstrictors in human uterine blood vessels.

Authors:  G Fried; U Samuelson
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

Review 3.  Current topic: pre-eclampsia and the placenta.

Authors:  C W Redman
Journal:  Placenta       Date:  1991 Jul-Aug       Impact factor: 3.481

4.  Changes in uterine blood flow during human pregnancy.

Authors:  I Thaler; D Manor; J Itskovitz; S Rottem; N Levit; I Timor-Tritsch; J M Brandes
Journal:  Am J Obstet Gynecol       Date:  1990-01       Impact factor: 8.661

5.  Preeclampsia: an endothelial cell disorder.

Authors:  J M Roberts; R N Taylor; T J Musci; G M Rodgers; C A Hubel; M K McLaughlin
Journal:  Am J Obstet Gynecol       Date:  1989-11       Impact factor: 8.661

Review 6.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy.

Authors:  James M Roberts; Gail Pearson; Jeff Cutler; Marshall Lindheimer
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

7.  Maternal placental blood flow is reduced in proportion to reduction in uterine driving pressure.

Authors:  M R Laird; J J Faber; N D Binder
Journal:  Pediatr Res       Date:  1994-07       Impact factor: 3.756

8.  Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits.

Authors:  G Losonczy; G Brown; R C Venuto
Journal:  Am J Med Sci       Date:  1992-04       Impact factor: 2.378

9.  The intrauterine to intra-arterial pressure ratio: a new parameter for the study of uterine contractility physiology.

Authors:  R Dittrich; C Sinduwinatha; T Maltaris; A Mueller; I Hoffmann; M W Beckmann; P G Oppelt
Journal:  Reprod Biomed Online       Date:  2009-12-11       Impact factor: 3.828

10.  Effect of endothelin-1 on the uterine vasculature of the pregnant and estrogen-treated nonpregnant sheep.

Authors:  D Yang; K E Clark
Journal:  Am J Obstet Gynecol       Date:  1992-12       Impact factor: 8.661

View more
  38 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.

Authors:  Kedra Wallace; Sarah Novotny; Judith Heath; Janae Moseley; James N Martin; Michelle Y Owens; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-30       Impact factor: 3.619

3.  Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.

Authors:  Lorena M Amaral; Jessica L Faulkner; Jamil Elfarra; Denise C Cornelius; Mark W Cunningham; Tarek Ibrahim; Venkata Ramana Vaka; Jessica McKenzie; Babbette LaMarca
Journal:  Hypertension       Date:  2017-10-30       Impact factor: 10.190

4.  Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.

Authors:  Jesse N Cottrell; Lorena M Amaral; Ashlyn Harmon; Denise C Cornelius; Mark W Cunningham; Venkata Ramana Vaka; Tarek Ibrahim; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

5.  The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia.

Authors:  Ellen E Gillis; Jan M Williams; Michael R Garrett; Jennifer N Mooney; Jennifer M Sasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-04-22       Impact factor: 3.619

Review 6.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

7.  An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.

Authors:  Denise C Cornelius; Lorena M Amaral; Ashlyn Harmon; Kedra Wallace; Alexia J Thomas; Nathan Campbell; Jeremy Scott; Florian Herse; Nadine Haase; Janae Moseley; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

8.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

9.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

10.  Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.

Authors:  Jose A Santiago-Font; Lorena M Amaral; Jessica Faulkner; Tarek Ibrahim; Venkata Ramana Vaka; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.